Related Experiment Video
Updated: Mar 14, 2026
07:45
Author Spotlight: Standardizing Mouse In Vivo PET Imaging with Body Conforming Molds and Automated Analysis
Published on: October 25, 2024
861
Molecular imaging in oncology drug development.
Sarah R Mudd1, Robert A Comley1, Mats Bergstrom2
1AbbVie, 1 North Waukegan Road, North Chicago, IL 60064, USA.
Drug Discovery Today
|October 4, 2016
Summary
Molecular imaging accelerates cancer drug development by improving early decisions and efficiency. This approach helps reduce the high costs associated with bringing new cancer therapeutics to patients.
Area of Science:
- Oncology
- Molecular Imaging
- Drug Development
Background:
- Cancer drug discovery faces significant financial costs.
- Increasing pressure on drug pricing necessitates efficient therapeutic development.
- Advancements in cancer therapeutics require streamlined delivery to patients.
Purpose of the Study:
- To review the applications of molecular imaging in oncology drug development.
- To highlight how molecular imaging enhances early decision-making.
- To demonstrate the potential of molecular imaging to increase efficiency and reduce costs.
Main Methods:
- Review of current literature on molecular imaging in oncology.
- Analysis of case studies demonstrating molecular imaging's impact on drug development.
- Discussion of the role of molecular imaging in optimizing clinical trial design.
Main Results:
- Molecular imaging provides critical data for early go/no-go decisions in drug development.
- It enables more precise patient stratification and monitoring of treatment response.
- Integration of molecular imaging can significantly shorten development timelines and lower overall costs.
Conclusions:
- Molecular imaging is a valuable tool for efficient oncology drug development.
- Its application supports better-informed decisions, leading to cost savings.
- Adoption of molecular imaging can accelerate the delivery of novel cancer therapeutics.
